Display options
Cite
Kaplan JB, Izano EA, Gopal P, et al. Low levels of β-lactam antibiotics induce extracellular DNA release and biofilm formation in Staphylococcus aureus. mBio. 2012;3(4):e00198-12doi: 10.1128/mBio.00198-12.
Kaplan, J. B., Izano, E. A., Gopal, P., Karwacki, M. T., Kim, S., Bose, J. L., Bayles, K. W., & Horswill, A. R. (2012). Low levels of β-lactam antibiotics induce extracellular DNA release and biofilm formation in Staphylococcus aureus. mBio, 3(4), e00198-12. https://doi.org/10.1128/mBio.00198-12
Kaplan, Jeffrey B, et al. "Low levels of β-lactam antibiotics induce extracellular DNA release and biofilm formation in Staphylococcus aureus." mBio vol. 3,4 (2012): e00198-12. doi: https://doi.org/10.1128/mBio.00198-12
Kaplan JB, Izano EA, Gopal P, Karwacki MT, Kim S, Bose JL, Bayles KW, Horswill AR. Low levels of β-lactam antibiotics induce extracellular DNA release and biofilm formation in Staphylococcus aureus. mBio. 2012 Jul 31;3(4):e00198-12. doi: 10.1128/mBio.00198-12. Print 2012. PMID: 22851659; PMCID: PMC3419523.
Copy Download .nbib Format: NLM
Share it on

mBio. 2012 Jul 31;3(4):e00198-12. doi: 10.1128/mBio.00198-12. Print 2012.

Low levels of β-lactam antibiotics induce extracellular DNA release and biofilm formation in Staphylococcus aureus.

mBio

Jeffrey B Kaplan, Era A Izano, Prerna Gopal, Michael T Karwacki, Sangho Kim, Jeffrey L Bose, Kenneth W Bayles, Alexander R Horswill

Affiliations

  1. Department of Oral Biology, New Jersey Dental School, Newark, NJ, USA. [email protected]

PMID: 22851659 PMCID: PMC3419523 DOI: 10.1128/mBio.00198-12

Abstract

UNLABELLED: Subminimal inhibitory concentrations of antibiotics have been shown to induce bacterial biofilm formation. Few studies have investigated antibiotic-induced biofilm formation in Staphylococcus aureus, an important human pathogen. Our goal was to measure S. aureus biofilm formation in the presence of low levels of β-lactam antibiotics. Fifteen phylogenetically diverse methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive S. aureus (MSSA) strains were employed. Methicillin, ampicillin, amoxicillin, and cloxacillin were added to cultures at concentrations ranging from 0× to 1× MIC. Biofilm formation was measured in 96-well microtiter plates using a crystal violet binding assay. Autoaggregation was measured using a visual test tube settling assay. Extracellular DNA was quantitated using agarose gel electrophoresis. All four antibiotics induced biofilm formation in some strains. The amount of biofilm induction was as high as 10-fold and was inversely proportional to the amount of biofilm produced by the strain in the absence of antibiotics. MRSA strains of lineages USA300, USA400, and USA500 exhibited the highest levels of methicillin-induced biofilm induction. Biofilm formation induced by low-level methicillin was inhibited by DNase. Low-level methicillin also induced DNase-sensitive autoaggregation and extracellular DNA release. The biofilm induction phenotype was absent in a strain deficient in autolysin (atl). Our findings demonstrate that subminimal inhibitory concentrations of β-lactam antibiotics significantly induce autolysin-dependent extracellular DNA release and biofilm formation in some strains of S. aureus.

IMPORTANCE: The widespread use of antibiotics as growth promoters in agriculture may expose bacteria to low levels of the drugs. The aim of this study was to investigate the effects of low levels of antibiotics on bacterial autoaggregation and biofilm formation, two processes that have been shown to foster genetic exchange and antibiotic resistance. We found that low levels of β-lactam antibiotics, a class commonly used in both clinical and agricultural settings, caused significant autoaggregation and biofilm formation by the important human pathogen Staphylococcus aureus. Both processes were dependent on cell lysis and release of DNA into the environment. The effect was most pronounced among multidrug-resistant strains known as methicillin-resistant S. aureus (MRSA). These results may shed light on the recalcitrance of some bacterial infections to antibiotic treatment in clinical settings and the evolution of antibiotic-resistant bacteria in agricultural settings.

References

  1. J Basic Microbiol. 2011 Apr;51(2):191-5 - PubMed
  2. J Antimicrob Chemother. 1994 Apr;33(4):845-8 - PubMed
  3. Clin Microbiol Rev. 2011 Oct;24(4):718-33 - PubMed
  4. PLoS Pathog. 2012;8(4):e1002626 - PubMed
  5. Virulence. 2011 Sep-Oct;2(5):445-59 - PubMed
  6. Lancet. 2002 May 25;359(9320):1819-27 - PubMed
  7. Int J Antimicrob Agents. 2001 Jan;17(1):1-8 - PubMed
  8. Eur J Clin Microbiol Infect Dis. 1992 Aug;11(8):732-7 - PubMed
  9. Antimicrob Agents Chemother. 1997 May;41(5):906-13 - PubMed
  10. Infect Immun. 2011 Mar;79(3):1153-65 - PubMed
  11. J Antibiot (Tokyo). 2012 Feb;65(2):73-7 - PubMed
  12. Res Microbiol. 2011 Jun;162(5):535-41 - PubMed
  13. J Bacteriol. 2009 Feb;191(3):832-43 - PubMed
  14. Clin Microbiol Infect. 2006 Dec;12(12):1154-62 - PubMed
  15. J Appl Microbiol. 2010 Apr;108(4):1281-91 - PubMed
  16. J Bacteriol. 2005 Apr;187(7):2426-38 - PubMed
  17. Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9786-91 - PubMed
  18. J Antimicrob Chemother. 2010 Sep;65(9):1955-8 - PubMed
  19. Trends Pharmacol Sci. 2001 Jun;22(6):285-91 - PubMed
  20. Lancet. 2001 Apr 21;357(9264):1225-40 - PubMed
  21. PLoS Pathog. 2007 Jul 27;3(7):e102 - PubMed
  22. PLoS Pathog. 2008 Apr 25;4(4):e1000052 - PubMed
  23. PLoS One. 2011;6(11):e26714 - PubMed
  24. J Microbiol Methods. 2004 Dec;59(3):363-70 - PubMed
  25. Infect Immun. 1985 Sep;49(3):765-9 - PubMed
  26. PLoS One. 2009 Jun 09;4(6):e5822 - PubMed
  27. Infect Immun. 2002 Jul;70(7):3978-81 - PubMed
  28. Appl Environ Microbiol. 2008 Jan;74(2):470-6 - PubMed
  29. Lancet. 2006 Mar 4;367(9512):731-9 - PubMed
  30. Antimicrob Agents Chemother. 1993 Apr;37(4):921-3 - PubMed
  31. Infect Immun. 2005 Aug;73(8):4596-606 - PubMed
  32. Int J Artif Organs. 2011 Sep;34(9):737-51 - PubMed
  33. Proc Natl Acad Sci U S A. 2007 May 8;104(19):8113-8 - PubMed
  34. PLoS One. 2012;7(7):e42244 - PubMed
  35. J Gen Microbiol. 1952 Feb;6(1-2):95-107 - PubMed
  36. J Bacteriol. 2002 Oct;184(19):5457-67 - PubMed
  37. Adv Exp Med Biol. 2011;715:105-23 - PubMed
  38. Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6434-9 - PubMed
  39. PLoS One. 2010 Apr 14;5(4):e10146 - PubMed
  40. PLoS One. 2008;3(10):e3361 - PubMed
  41. J Antimicrob Chemother. 2011 May;66(5):979-84 - PubMed
  42. Antimicrob Agents Chemother. 2007 Mar;51(3):888-95 - PubMed

Substances

MeSH terms

Publication Types

Grant support